gadolinium dtpa has been researched along with cellobionic acid in 1 studies
| Studies (gadolinium dtpa) | Trials (gadolinium dtpa) | Recent Studies (post-2010) (gadolinium dtpa) | Studies (cellobionic acid) | Trials (cellobionic acid) | Recent Studies (post-2010) (cellobionic acid) |
|---|---|---|---|---|---|
| 12,654 | 664 | 4,051 | 21 | 0 | 16 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Du, H; He, Y; Jia, B; Lam, KS; Li, Y; Lin, TY; Lu, H; Ma, Z; Manna, SK; Qu, H; Ramachandran, M; Shen, Y; Wang, Z; Wu, H; Xiao, W; Xu, X; Xue, X; Yang, J; Zawadzki, RJ | 1 |
1 other study(ies) available for gadolinium dtpa and cellobionic acid
| Article | Year |
|---|---|
Sequential Targeting in Crosslinking Nanotheranostics for Tackling the Multibarriers of Brain Tumors.
Topics: Animals; Antineoplastic Agents; Blood-Brain Barrier; Boronic Acids; Brain; Brain Neoplasms; Carbocyanines; Cell Line, Tumor; Disaccharides; Drug Carriers; Gadolinium DTPA; Glioma; Humans; Hydrogen-Ion Concentration; Kaplan-Meier Estimate; Mice; Mice, Inbred BALB C; Nanoparticles; Transcytosis; Xenograft Model Antitumor Assays | 2020 |